Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Study of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) Infection

ClinicalTrials.gov ID: NCT06784973

Public ClinicalTrials.gov record NCT06784973. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 11:00 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Obeldesivir in Participants From Birth to < 5 Years of Age With Respiratory Syncytial Virus (RSV) Infection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of this clinical study is to check if obeldesivir (ODV; GS-5245) is safe and well-tolerated by children with respiratory syncytial virus (RSV) infection. It will also look at how well ODV helps reduce the time it takes for children to feel better and for their RSV symptoms to improve. The primary objectives of this study are: a) to evaluate the safety and tolerability of ODV in pediatric participants with RSV infection; b) To evaluate the efficacy of ODV on time to alleviation of targeted RSV symptoms in pediatric participants with RSV infection.

Study identification

NCT ID
NCT06784973
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gilead Sciences
Industry
Enrollment
4 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
Up to 5 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 4, 2025
Primary completion
Apr 15, 2025
Completion
Apr 15, 2025
Last update posted
Jun 7, 2026

2025

United States locations

U.S. sites
41
U.S. states
16
U.S. cities
36
Facility City State ZIP Site status
Children's of Alabama Birmingham Alabama 35233
Midway Medical Clinic Oneonta Alabama 35121
Cohen Children's Medical Center Pharmacy New Pavillion Phoenix Arizona 11040
Velocity Clinical Research, Phoenix Phoenix Arizona 85015
UCLA (Outpatient Clinic) Los Angeles California 90095
Alliance Research Institute Lynwood California 90262
Paradigm Clinical Research Modesto California 95355
Paradigm Clinical Research Centers, LLC San Diego California 92108
FOMAT - Jeffrey Kaplan MD Inc Pediatric Medicine Santa Maria California 93454
Velocity Clinical Research, Washington DC Washington D.C. District of Columbia 20016
Dolphin Medical Research Doral Florida 33172
Nona Pediatric Center Orlando Florida 32829
PAS Research Tampa Florida 33613
Rophe Adult and Pediatric Medicine/SKYCRNG Union City Georgia 30291
Clinical Research Prime Idaho Falls Idaho 83404
Velocity Clinical Research, Sioux City Sioux City Iowa 51106
Velocity Clinical Research, Lafayette Lafayette Louisiana 70508
Boeson Research Great Falls Montana 59405
Boeson Research Kalispell Montana 59901
Boeson Research Missoula Montana 59804
Velocity Clinical Research - Norfolk Norfolk Nebraska 68701
Velocity Clinical Research, Omaha Omaha Nebraska 68134
Child Health Care Associates Syracuse New York 13210
Epic Medical Research -Oklahoma Chickasha Oklahoma 73018
Tekton Research, LLC Yukon Oklahoma 73099
PAS Research Pittsburgh Pennsylvania 15227
Helios Clinical Research Burleson Texas 76028
Epic Medical Research - DeSoto DeSoto Texas 75115
PAS Research Edinburg Texas 78539
Helios Clinical Research Houston Texas 77008
Biopharma Informatic, LLC Houston Texas 77043
Sunrise Pediatrics Houston Texas 77077
Biopharma Informatic, LLC Houston Texas 77084
Pioneer Research Solutions Inc. Houston Texas 77099
Radiance Clinical Research Lampasas Texas 76550
Pediatric Center Richmond Texas 77469
Central Texas Medical Research, LLC San Antonio Texas 78232
North Houston Internal Medicine and Pediatric Clinic Tomball Texas 77375
Tanner Clinic Kaysville Utah 84037
Tanner Clinic Layton Utah 84041
Boeson Research PVU Provo Utah 84604

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06784973, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 7, 2026 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06784973 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →